Chapter 39: Intellectual Disability

Intellectual disability represents a neurodevelopmental condition defined by significant impairments in intellectual functioning and adaptive behavior emerging during the developmental period. This chapter traces the evolution from historically restrictive intelligence quotient-based definitions toward contemporary diagnostic approaches that assess competence across conceptual, social, and practical domains as outlined in the DSM-5-TR and ICD-11 frameworks. Approximately one percent of the population experiences intellectual disability with varying severity levels, though prevalence rates demonstrate notable disparities related to socioeconomic status and cultural factors. The etiology encompasses diverse mechanisms including chromosomal and single-gene disorders such as Down syndrome, Fragile X syndrome, Rett syndrome, and Prader-Willi syndrome, alongside prenatal exposures including maternal infections, teratogenic substances, and nutritional deficiencies. Perinatal complications including birth asphyxia and traumatic delivery, combined with postnatal factors such as traumatic brain injury, infections, neurotoxic exposures, and environmental deprivation, account for substantial portions of cases. Molecular genetic advances including chromosomal microarray analysis and whole-exome sequencing have dramatically expanded identification of genetic contributions, revealing hundreds of implicated genetic loci. Neurobiological investigation documents widespread structural and functional brain abnormalities particularly affecting the prefrontal cortex, hippocampus, and neural networks essential for executive function and learning capacity. Clinical presentation varies with severity but characteristically includes developmental delay, language dysfunction, impaired problem-solving, reduced adaptive capacities, and frequent concurrent conditions including attention-deficit hyperactivity disorder, autism spectrum disorder, epilepsy, mood disturbances, and self-injurious behaviors. Management emphasizes early detection and intervention tailored to individual strengths and developmental potential, incorporating early stimulation programs, behavioral modification, specialized education, speech pathology, occupational rehabilitation, family-centered support, and judicious pharmacotherapy for comorbid conditions. Outcomes correlate strongly with severity level and availability of environmental supports, with individuals experiencing mild disability frequently achieving substantial independence when provided appropriate resources and services. The chapter emphasizes ethical dimensions including protection against stigma, promotion of individual rights, and community inclusion as integral components of comprehensive care.